Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Formin Homology 2 (FH2) domain is a highly conserved protein structural motif found in the formin family of proteins, which are key regulators of the actin and microtubule cytoskeleton [6, 10]. Functioning as a homodimer, the FH2 domain forms a characteristic donut-shaped structure that nucleates new actin filaments and processively tracks the growing barbed ends, protecting them from capping proteins while allowing for rapid elongation [8, 11]. Because formins are essential for fundamental cellular processes such as cytokinesis, cell migration, and morphogenesis, the FH2 domain has emerged as a potential therapeutic target for diseases characterized by aberrant cytoskeletal dynamics, including cancer metastasis and various genetic disorders [7, 16]. Small molecule inhibitors like SMIFH2 have been developed to block the FH2 domain activity, providing valuable tools for research and a starting point for drug discovery [1, 4]. However, achieving isoform specificity among the 15 human formins and avoiding off-target effects on other cytoskeletal proteins like myosins remain significant challenges in the development of formin-targeted therapies [1, 13].
Inhibition of actin nucleation and elongation by binding to the FH2 domain and preventing its interaction with actin monomers and filaments.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Formin homology 2 domain (FH2).